MNMD
NASDAQ
Denium Therapeutics, Inc - Common Shares
Healthcare
· Pharmaceuticals
$18.09
▼ $-0.23
(-1.26%)
Vol 1.5M
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$1.3B
ROE
-86.2%
D/E
30.92
Beta
2.69
52W
$5–$14
Price Chart
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -50.2% | -50.2% | -50.2% | -50.2% | -86.2% | -86.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 22.22 | 22.22 | 22.22 | 22.22 | 30.92 | 30.92 |
| Current Ratio | 4.98 | 4.98 | 4.98 | 4.98 | 3.30 | 3.30 |
Key Ratios
ROA (TTM)
-62.3%
P/B
2.1
EPS (TTM)
$-1.97
CF/Share
$-1.91
52W High
$14.43
52W Low
$4.70
$4.70
52-Week Range
$14.43
How does MNMD compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
MNMD valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
2.1
▼
0%
below
peers
(2.1)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
MNMD profitability vs Pharmaceuticals peers
ROE
-86.2%
▼
59%
below
peers
(-54.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(68.3%)
vs Peers
vs Industry
In line
ROA
-62.3%
▼
66%
below
peers
(-37.4%)
vs Peers
vs Industry
Weak
MNMD financial health vs Pharmaceuticals peers
D/E ratio
30.9
▲
1908%
above
peers
(1.5)
vs Peers
vs Industry
High debt
Current ratio
3.3
▼
2%
below
peers
(3.4)
vs Peers
vs Industry
In line
Beta
2.7
▲
187%
above
peers
(0.9)
vs Peers
vs Industry
More volatile
MNMD fundamentals radar
MNMD
Peer median
Industry
MNMD profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
MNMD vs peers: key metrics
Latest News
No related news yet